Subjects: MERCK KGaA; PEMBROLIZUMAB; ADVERSE health care events
Record details
Subjects: FIBRINOLYTIC agents; RESEARCH; STROKEAUSTRALIA
Subjects: COVID-19 vaccines; IMMUNE response; VACCINESCHAD
Subjects: HEPATITIS C virus; HEPATITIS C; HIV-positive persons
Subjects: EPIDERMAL growth factor; MELANOMA; GENETICS of disease susceptibility
Subjects: HIV; HAEMOPHILUS diseases; MEDICAL research